UNDERSTANDING FOLLICULAR LYMPHOMA: A SLOW-GROWING NON-HODGKIN’S LYMPHOMA Follicular Lymphoma is a subtype of non-Hodgkin lymphoma that originates in white blood cells known as lymphocytes, which ...

Why ‘watch and wait’ with follicular lymphoma? Learn why no treatment may be the best treatment with this slow-growing cancer.

Because follicular lymphoma isn’t currently curable, there’s always a chance it will come back if it goes into remission. There’s also a chance that your cancer won’t respond to the first ...

The U.S. Food and Drug Administration has approved Monjuvi (tafasitamab-cxix) for the treatment of adult patients with relapsed or refractory follicular lymphoma. Monjuvi is a humanized Fc ...

Of note, the risk of lymphoma was highest in those with less than 2 years between their first tattoo and the index year (IRR 1.81, 95% CI 1.03-3.20), and decreased with intermediate exposure ...

Dec 23 (Reuters) - The U.S. health regulator has approved Roche Holding AG's (ROG.S), opens new tab therapy for treating a type of rare cancer called follicular lymphoma. The U.S. Food and Drug ...

CHICAGO — In this video, Ian W. Flinn, MD, PhD, discusses the phase 2 MorningSun study evaluating fixed-duration subcutaneous mosunetuzumab in patients with previously untreated, high-tumor ...

B-cell lymphoma is a type of cancer originating from abnormal growth and proliferation of B lymphocytes and can be divided into different sub-types including diffuse large B-cell lymphoma (DLBCL ...